(Q40401618)

English

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis

scientific article published on 25 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

author name string

Iris Valdés

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lisset Hermida

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jorge Martín

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tamara Menéndez

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lázaro Gil

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Laura Lazo

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jorge Castro

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Olivia Niebla

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Carlos López

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lídice Bernardo

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jorge Sánchez

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yaremis Romero

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Rafael Martínez

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

María G Guzmán

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gerardo Guillén

15

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

25 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

995-1001

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Mannose receptor-mediated regulation of serum glycoprotein homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Cysteine mediated multimerization of a recombinant dengue E fragment fused to the P64k protein following immobilized metal ion affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Ligand recognition by antigen-presenting cell C-type lectin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

based on heuristic

inferred from DOI database lookup

Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.106

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.11.106

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40401618&oldid=1896941891"